Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B

The use of new adjuvants in vaccine formulations is a subject of current research. Only few parenteral adjuvants have been licensed. We have developed a mucosal and parenteral adjuvant known as AFCo1 (Adjuvant Finlay Cochleate 1, derived from proteoliposomes of N. meningitidis B) using a dialysis pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zayas, Caridad, González, Domingo, Acevedo, Reinaldo, del Campo, Judith, Lastre, Miriam, González, Elizabeth, Romeu, Belkis, Cuello, Maribel, Balboa, Julio, Cabrera, Osmir, Guilherme, Luisa, Pérez, Oliver
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Proceedings
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3582446/
https://ncbi.nlm.nih.gov/pubmed/23458578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2172-14-S1-S4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars